Mereo Stock Market Value

MREO
 Stock
  

USD 0.82  0.02  2.38%   

Mereo Biopharma's market value is the price at which a share of Mereo Biopharma stock trades on a public exchange. It measures the collective expectations of Mereo Biopharma Group investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Mereo Biopharma Group and determine expected loss or profit from investing in Mereo Biopharma over a given investment horizon. Additionally, see Mereo Biopharma Correlation, Mereo Biopharma Volatility and Mereo Biopharma Alpha and Beta module to complement your research on Mereo Biopharma.
Symbol


Is Mereo Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mereo Biopharma. If investors know Mereo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mereo Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mereo Biopharma Group is measured differently than its book value, which is the value of Mereo that is recorded on the company's balance sheet. Investors also form their own opinion of Mereo Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Mereo Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mereo Biopharma's market value can be influenced by many factors that don't directly affect Mereo Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mereo Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Mereo Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mereo Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Mereo Biopharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mereo Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mereo Biopharma.
0.00
07/29/2022
No Change 0.00  0.0 
In 2 months and 1 day
09/27/2022
0.00
If you would invest  0.00  in Mereo Biopharma on July 29, 2022 and sell it all today you would earn a total of 0.00 from holding Mereo Biopharma Group or generate 0.0% return on investment in Mereo Biopharma over 60 days. Mereo Biopharma is related to or competes with Clearwater Paper. Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of on... More

Mereo Biopharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mereo Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mereo Biopharma Group upside and downside potential and time the market with a certain degree of confidence.

Mereo Biopharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Mereo Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mereo Biopharma's standard deviation. In reality, there are many statistical measures that can use Mereo Biopharma historical prices to predict the future Mereo Biopharma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Mereo Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Mereo Biopharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.050.917.66
Details
Intrinsic
Valuation
LowReal ValueHigh
0.142.869.61
Details
Naive
Forecast
LowNext ValueHigh
0.0175810.887.62
Details
1 Analysts
Consensus
LowTarget PriceHigh
8.009.0010.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Mereo Biopharma. Your research has to be compared to or analyzed against Mereo Biopharma's peers to derive any actionable benefits. When done correctly, Mereo Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Mereo Biopharma Group.

Mereo Biopharma Group Backtested Returns

Mereo Biopharma Group has Sharpe Ratio of -0.0882, which conveys that the firm had -0.0882% of return per unit of risk over the last 3 months. Macroaxis standpoint towards estimating the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Mereo Biopharma exposes twenty-seven different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify Mereo Biopharma Group mean deviation of 4.66, and Risk Adjusted Performance of (0.1) to check out the risk estimate we provide.
The company secures a Beta (Market Risk) of 1.8832, which conveys a somewhat significant risk relative to the market. Let's try to break down what Mereo's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mereo Biopharma will likely underperform. Even though it is essential to pay attention to Mereo Biopharma Group price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Mereo Biopharma exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Mereo Biopharma Group has an expected return of -0.59%. Please be advised to verify Mereo Biopharma Group value at risk, as well as the relationship between the skewness and day median price to decide if Mereo Biopharma Group performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.55  

Good reverse predictability

Mereo Biopharma Group has good reverse predictability. Overlapping area represents the amount of predictability between Mereo Biopharma time series from 29th of July 2022 to 28th of August 2022 and 28th of August 2022 to 27th of September 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mereo Biopharma Group price movement. The serial correlation of -0.55 indicates that about 55.0% of current Mereo Biopharma price fluctuation can be explain by its past prices.
Correlation Coefficient-0.55
Spearman Rank Test-0.35
Residual Average0.0
Price Variance0.02

Mereo Biopharma Group lagged returns against current returns

Autocorrelation, which is Mereo Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mereo Biopharma's stock expected returns. We can calculate the autocorrelation of Mereo Biopharma returns to help us make a trade decision. For example, suppose you find that Mereo Biopharma stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   
Share
       Timeline  

Mereo Biopharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mereo Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mereo Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mereo Biopharma stock over time.
   Current vs Lagged Prices   
Share
       Timeline  

Mereo Biopharma Lagged Returns

When evaluating Mereo Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mereo Biopharma stock have on its future price. Mereo Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mereo Biopharma autocorrelation shows the relationship between Mereo Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Mereo Biopharma Group.
   Regressed Prices   
Share
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mereo Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mereo Biopharma's short interest history, or implied volatility extrapolated from Mereo Biopharma options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Mereo Biopharma Group using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Mereo Biopharma Correlation, Mereo Biopharma Volatility and Mereo Biopharma Alpha and Beta module to complement your research on Mereo Biopharma. Note that the Mereo Biopharma Group information on this page should be used as a complementary analysis to other Mereo Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Mereo Stock analysis

When running Mereo Biopharma Group price analysis, check to measure Mereo Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo Biopharma is operating at the current time. Most of Mereo Biopharma's value examination focuses on studying past and present price action to predict the probability of Mereo Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mereo Biopharma's price. Additionally, you may evaluate how the addition of Mereo Biopharma to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Mereo Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mereo Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mereo Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...